AMERICAN SHARED HOSPITAL SERVICES AMS

AMEX Price as of Nov 13, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026

$1.09
$0.9800
$2.39
Market cap
$7.25M
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
19.2%
EPS growth YoY
-75.0%
ROIC
-7.5%
Piotroski F-score
5

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) 19.2% 15.9%+3.3 pts 0.2%+19.0 pts
EPS growth YoY (qtr) -75.0% 10.0%-85.0 pts -107.3%+32.3 pts
Revenue growth (TTM) 4.0% -0.6%+4.6 pts 26.6%-22.6 pts
EPS growth (TTM) 34.2% -204.8%+239.0 pts -157.6%+191.8 pts
P/E (GAAP, TTM) — —— ——
P/E (operating) — —— ——
P/E (excl. gains) — —— ——
P/B 0.39 0.43-0.04 ——
ROIC -7.5% -7.5%0.0 pts -8.2%+0.7 pts
Net margin -5.5% -5.5%0.0 pts 7.7%-13.2 pts
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -0.25 -0.22-13.6% -0.38+34.2%
Price $1.42 $1.57-9.6% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Jun 30, 2026 $8.43M 19.0% 19.2% -0.07 22.2% -75.0% -6.1%
Mar 31, 2026 $7.08M -8.3% 15.9% -0.09 0.0% 10.0% -8.6%
Dec 31, 2025 * $7.73M 7.8% -14.8% -0.09 — 57.1% -8.2%
Sep 30, 2025 $7.17M 1.4% 2.5% 0.00 100.0% 100.0% -0.2%
Jun 30, 2025 $7.07M 15.7% 0.2% -0.04 60.0% -107.3% -4.0%
Mar 31, 2025 $6.11M -32.6% 17.2% -0.10 52.4% -600.0% -10.2%
Dec 31, 2024 * $9.07M 29.6% 59.2% -0.21 -600.0% -400.0% -14.6%
Sep 30, 2024 $7.00M -0.8% 36.3% -0.03 -105.5% -250.0% -3.0%
Jun 30, 2024 $7.06M 35.3% 26.7% 0.55 2,650.0% 2,850.0% 51.0%
Mar 31, 2024 $5.22M -8.5% 5.9% 0.02 -71.4% -33.3% 2.3%
Dec 31, 2023 * $5.70M 11.0% 13.1% 0.07 250.0% 75.0% 7.3%
Sep 30, 2023 $5.13M -7.8% 6.3% 0.02 200.0% -60.0% 2.3%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 13, 2026 Date of the latest closing price used.
Price $1.09 Latest closing price.
Market cap $7.25M Price × shares outstanding.
Enterprise value $21.08M Market cap + debt − cash: the price of the whole business.
Shares 6.65M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -21.4% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -22.9% TTM EPS ÷ price.
P/B 0.30 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 0.26 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 0.24 Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA 9.92 Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 0.75 Enterprise value ÷ revenue.
Book value / share 3.61 Shareholders' equity ÷ shares.
FCF yield -62.6% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS -0.43 After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains $0 One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income $368.00K Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Jun 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $8.43M Revenue of the latest reported quarter.
Net income (qtr) -$514.00K Net income of the latest reported quarter.
EPS (qtr) -0.07 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 19.2% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 19.0% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -75.0% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 22.2% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -83.6% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 16.0% Latest quarter net income vs the previous quarter.
Gross margin (qtr) 17.0% Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -10.8% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -6.1% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $30.41M Revenue of the last four quarters.
Net income (TTM) -$1.77M Net income of the last four quarters.
EPS (TTM) -0.25 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 4.0% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 34.2% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 27.3% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin 18.0% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin 7.6% EBITDA ÷ revenue.
Operating margin -12.8% Operating income ÷ revenue.
Net margin -5.5% Net income ÷ revenue.
FCF margin -16.2% Free cash flow ÷ revenue.
ROE -6.5% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -2.8% Return on assets: net income ÷ total assets.
ROIC -7.5% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) -0.9% Latest fiscal year revenue vs the year before.
Net income growth (annual) -171.0% Latest fiscal year net income vs the year before.
EPS growth (annual) -169.7% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 12.5% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 0.76 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 0.76 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.15 Cash ÷ current liabilities.
Debt / equity 0.72 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.31 Total debt ÷ total assets.
Debt / EBITDA 8.13 Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA 6.51 (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage -2.28 Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -8.4% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 1.4% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue 25.2% Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.51 Revenue ÷ total assets.
Days sales outstanding 137 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables 10 Average days to pay suppliers.
Trading & momentum
52-week high $2.39 Highest price in the last 52 weeks.
52-week low $0.9800 Lowest price in the last 52 weeks.
From 52-week high -54.4% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 11.2% How far above the 52-week low the price is.
Avg volume (30d) 9.71K Average shares traded per day over the last 30 days.
Avg $ volume (30d) $11.68K Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 5 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 0.43 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $28.08M Revenue of the latest fiscal year.
Net income -$1.55M Net income of the latest fiscal year.
Diluted EPS -0.23 Diluted earnings per share of the latest fiscal year.
EBITDA $2.13M Operating income + depreciation & amortization.
Free cash flow -$4.54M Operating cash flow − capital spending.
Total debt $17.29M Long-term plus current debt.
Cash $3.46M Cash and equivalents.
Equity $24.03M Shareholders' equity.
Total assets $55.48M Total assets.